These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36119438)
1. Mast Cell Sarcoma of the Retroperitoneum With Concurrent Systemic Mastocytosis and an Undisclosed Associated Hematologic Neoplasm: A Case Report. Chen I; Liao JB; Lin JC; Hsieh PP; Hsieh MY Clin Pathol; 2022; 15():2632010X221123539. PubMed ID: 36119438 [TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature. Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906 [TBL] [Abstract][Full Text] [Related]
3. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis. Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198 [TBL] [Abstract][Full Text] [Related]
4. Systemic Mastocytosis: Advances in Diagnosis and Current Management. Pullarkat ST; Wu W; Pullarkat V Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662 [TBL] [Abstract][Full Text] [Related]
7. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
8. Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review. Barozzi E; Bucelli C; Grifoni FI; Gianelli U; Iurlo A; Cattaneo D Front Oncol; 2021; 11():819097. PubMed ID: 35096623 [TBL] [Abstract][Full Text] [Related]
9. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment. Azaña JM; Torrelo A; Matito A Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106 [TBL] [Abstract][Full Text] [Related]
10. Precision Medicine in Systemic Mastocytosis. Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353 [TBL] [Abstract][Full Text] [Related]
11. Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case. Ghanem S; Garcia G; Ying L; Hurford M; Odaimi M Case Rep Oncol Med; 2016; 2016():3161768. PubMed ID: 27293930 [TBL] [Abstract][Full Text] [Related]
12. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy. Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556 [TBL] [Abstract][Full Text] [Related]